Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma
Author:
Affiliation:
1. Department of Pathology; Kawasaki Medical School; Kurashiki Japan
2. Department of Pathology; Teikyo University; Chiba Medical Centre; Ichihara Japan
3. Department of Haematology; Kawasaki Medical School; Kurashiki Japan
Funder
Japan Society for the Promotion of Science
Kawasaki Medical School
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14054/fullpdf
Reference41 articles.
1. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 in vascular and lymphatic endothelial cells;Akiyama;Journal of Molecular Histology,2008
2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000
3. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2;Alvarez;Nature,2010
4. An update on the biology of sphingosine 1-phosphate receptors;Blaho;Journal of Lipid Research,2014
5. Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy;Carbone;Annals of Hematology,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma;Journal of Experimental & Clinical Cancer Research;2023-01-05
2. Sphingolipids and Lymphomas: A Double-Edged Sword;Cancers;2022-04-19
3. S1PR1 signaling in cancer: A current perspective;Advances in Protein Chemistry and Structural Biology;2021
4. OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma;Cancer Medicine;2020-01-09
5. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy;Molecular Diagnosis & Therapy;2019-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3